EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment

Dong Hyun Kim iD, Jong Seok Ahn iD, Mingu Kang, Gahee Park, Yoojoo Lim iD, Soohyun Hwang, Chan-Young Ock iD, Jiwon Koh, Eun-Jae Chung, Seong-Keun Kwon, Yoon Kyung Jeon iD, Kyeong Cheon Jung und 2 weitere

Cells · 16.09.2024 · 13 (18) · 1557

DOI: 10.3390/cells13181557 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cells, online erschienen am 16.09.2024. Verfasst von Dong Hyun Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immune Checkpoint Inhibitors, Squamous Cell Carcinoma of Head and Neck, Lymphatic Metastasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation (NRF) funded by the Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The relationship between tumor microenvironments (TMEs) of regional lymph node metastases (LNMs) and primary tumors in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study compared tumor-infiltrating lymphocytes (TILs) and the immune phenotype (IP), characterized by spatial TIL distribution, between primary tumors and LNMs. Twenty-one HNSCC patients with regional LNM who received immune checkpoint inhibitors (ICIs) were included. A paired comparative analysis of TIL densities and IP between primary tumors and LNMs revealed no significant difference or correlation between TIL densities in primary tumors and LNMs. Their IPs were discordant in 12 patients (57.1%). Patients with high intratumoral TIL exhibited longer progression-free survival (PFS) than those with low intratumoral TIL in both primary tumors (median, 5.2 vs. 1.3 months, p = 0.003) and LNMs (median, 30.2 vs. 1.3 months, p = 0.012). Patients with inflamed IP exhibited longer PFS than those with non-inflamed IP in both primary tumors (median, 4.5 vs. 1.3 months, p = 0.043) and LNMs (median, 4.1 vs. 1.3 months, p = 0.037). Given the lack of correlation in TIL densities, the discrepancies in IP, and the predictive value of both TMEs, evaluating the TMEs of both primary tumors and LNMs may be beneficial for the precise use of ICIs in HNSCC. There was a significant discordance between the TME of primary tumors and LNMs, with implications in survival outcomes. Therefore, evaluating the TME of both the primary tumor and LNM could be beneficial for the precise use of ICIs in HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentImmune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckLymphatic MetastasisLymphocytes, Tumor-InfiltratingHead and Neck NeoplasmsHumansMaleFemaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

head and neck squamous cell carcinomaimmune phenotypelymph node metastasistumor microenvironmenttumor-infiltrating lymphocyte

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Department of Translational Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Lunit Inc., Seoul 06241, Republic of Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Dong Hyun Kim, Jong Seok Ahn, Yoojoo Lim, Chan-Young Ock, Yoon Kyung Jeon, Bhumsuk Keam

Förderung

  • National Research Foundation (NRF) funded by the Korean government (MSIT)

Zitieren

APA

Kim, D. H., Ahn, J. S., Kang, M., Park, G., Lim, Y., Hwang, S., Ock, C. Y., Koh, J., Chung, E. J., Kwon, S. K., Jeon, Y. K., Jung, K. C., Ahn, S. H., & Keam, B. (2024). Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment. Cells, 13(18), 1557. https://doi.org/10.3390/cells13181557

Vancouver

Kim DH, Ahn JS, Kang M, Park G, Lim Y, Hwang S, et al. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment. Cells. 2024;13(18):1557. doi:10.3390/cells13181557

BibTeX
@article{Kim2024,
  author = {Kim, Dong Hyun and Ahn, Jong Seok and Kang, Mingu and Park, Gahee and Lim, Yoojoo and Hwang, Soohyun and Ock, Chan-Young and Koh, Jiwon and Chung, Eun-Jae and Kwon, Seong-Keun and Jeon, Yoon Kyung and Jung, Kyeong Cheon and Ahn, Soon-Hyun and Keam, Bhumsuk},
  title = {Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {1557},
  doi = {10.3390/cells13181557}
}
Kostenlos starten →